Clinical Trials Browser

Phase 1 × Interventional × Erythroplasia × Clear all

NCT05536037 2025-05-15

Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions

Phase 1 Terminated

Erythroplasia, Leukoplakia, Mouth Neoplasms

NCT03939364 2021-10-19

This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions

Phase 1 Withdrawn

Erythroplasia, Leukoplakia, Oral